Clinical trials have demonstrated substantial efficacy for tirzepatide
A 10mg/mL concentration allows 1.25mg doses at just 12.5 units, easy to measure on a standard insulin syringe
Healthcare providers should maintain a low threshold for testing given the potential for irreversible neurological damage if deficiency remains undetected and untreated
Long-term success: The program encourages the development of healthy habits that can be maintained long after treatment ends
This page goes deep into the mechanics of the dual GIP/GLP-1 agonist, explains why tirzepatide carries the highest risk of the entire drug class, and shows the clear difference between Mounjaro (diabetes) and Zepbound (obesity)
This includes statins , which treat high cholesterol, as well as other diabetes drugs , such as DPP-4 inhibitors like Januvia (sitagliptin)